Overall, the results of our experiments suggest that in HCC cells, the pro-apoptotic/antiproliferative attributes of ACN can be attributed to its suppression of STAT3 activation, thereby making a strong case for the further exploration of the potential of ACN to enhance the efficacy of treatment aimed at HCC patients while also lowering the associated toxicity. This evidence concerns the gene STAT3 and hepatocellular carcinoma.